• UCLA Health
  • myUCLAhealth
  • School of Medicine
Research

Research Programs

Research
  • Back to Division of Digestive Diseases
  • About Us
    • From the Chiefs
    • Clinical Trials and Studies
    • DDW Abstracts
    • Research Council
  • Themes
    • Brain-Gut Microbiome
    • Cancer
    • Inflammatory Bowel Disease
    • Interventional Endoscopy
    • Liver Disease
    • Metabolism and Obesity
  • Centers
    • Center for Inflammatory Bowel Diseases
    • Center for Obesity and METabolic Health (COMET)
    • Center for Systems Biomedicine
    • CURE: Digestive Diseases Research Center
    • G. Oppenheimer Center for Neurobiology of Stress and Resilience
  • Labs and Programs
    • Anton Laboratory
    • Beaven Laboratory
    • Benhammou Laboratory
    • Dong Laboratory
    • Han Laboratory
    • Hemostasis Research
    • Health Services Research
    • Hepatology Research
    • Hsiao Laboratory
    • Interventional Endoscopy Research
    • Jacob Laboratory
    • Jacobs Laboratory
    • Kaunitz Laboratory
    • Limketkai Laboratory
    • May Laboratory
    • Mulugeta Laboratory
    • Patel Laboratory
    • Pisegna Laboratory
    • Pothoulakis Laboratory
    • Rozengurt Laboratory
    • Saab Laboratory
    • Sachs Laboratory
    • Sternini Laboratory
    • Tabibian Laboratory
    • Taché Laboratory
    • Videlock Laboratory
  • Training Programs
    • Fellowship Seed Grants
    • GI Fellowship Program
    • NIH T32 Training Grant
    • Specialty Training and Advanced Research (STAR) Program
  • Research Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Research Programs

Labs and Programs

Labs and Programs

Labs and Programs

  • Anton Laboratory
  • Beaven Laboratory
  • Benhammou Laboratory
  • Dong Laboratory
  • Han Laboratory
  • Hemostasis Research
  • Health Services Research
  • Hepatology Research
  • Hsiao Laboratory
  • Interventional Endoscopy Research
  • Jacob Laboratory
  • Jacobs Laboratory
  • Kaunitz Laboratory
  • Limketkai Laboratory
  • May Laboratory
  • Mulugeta Laboratory
  • Patel Laboratory
  • Pisegna Laboratory
  • Pothoulakis Laboratory
  • Rozengurt Laboratory
  • Saab Laboratory
  • Sachs Laboratory
  • Sternini Laboratory
  • Tabibian Laboratory
  • Taché Laboratory
  • Videlock Laboratory
  • Anton Laboratory
  • Beaven Laboratory
  • Benhammou Laboratory
  • Dong Laboratory
  • Han Laboratory
  • Hemostasis Research
  • Health Services Research
  • Hepatology Research
  • Hsiao Laboratory
  • Interventional Endoscopy Research
  • Jacob Laboratory
  • Jacobs Laboratory
  • Kaunitz Laboratory
  • Limketkai Laboratory
  • May Laboratory
  • Mulugeta Laboratory
  • Patel Laboratory
  • Pisegna Laboratory
  • Pothoulakis Laboratory
  • Rozengurt Laboratory
  • Saab Laboratory
  • Sachs Laboratory
  • Sternini Laboratory
  • Tabibian Laboratory
  • Taché Laboratory
  • Videlock Laboratory
  1. Home
  2. Research
  3. Labs and Programs
  4. Jacob Laboratory

Jacob Laboratory

Share this
Noam Jacob, MD, PhD

Key investigator

  • Noam Jacob, MD, PhD

Funding

  • Department of Veterans Affairs
  • UCLA

Current research projects

My research has focused on cellular and molecular mechanisms in autoimmunity and intestinal fibrosis

  • The role of cytokines responsible for inducing and/or mitigating intestinal inflammation and fibrosis
  • The contribution of the gut microbiome to intestinal fibrosis using in vivo and in vitro models

Future research directions

  • Evaluating the mechanisms responsible for induction of fibroblast-mediated fibrosis with direct and indirect microbial stimuli
  • Determining novel cellular pathways involved in intestinal fibrosis and inflammation

In the news

  • UCLA STAR Program Alumni Embark on Their Careers as Clinican-Scientists

Bio

Dr. Jacob graduated cum laude from the University of California, Berkeley where he studied philosophy and molecular biology. He then investigated immunologic mechanisms involving cytokines central to T cell, B cell and innate immune function in autoimmune diseases at the University of Southern California, prior to earning his medical degree from the Keck School of Medicine at USC. He completed specialty training in internal medicine at the Mount Sinai School of Medicine, New York and then joined UCLA as a gastroenterology fellow in 2014. He pursued additional research training at UCLA through the Specialty Training and Advanced Research (STAR) program where he received his PhD in molecular, cellular and integrative physiology. His doctoral work focused on the effects of tumor necrosis factor-like cytokine 1A and the microbiome on intestinal fibrosis in inflammatory bowel disease. He joined the Vatche and Tamar Manoukian Division of Digestive Diseases faculty at UCLA as an assistant professor-in-residence in 2018.


Lab members

Bo Qiao, MD

Bo Qiano, MD
Research Associate

Dr. Qiao earned his medical degree at Zhangjiakou Medical School in China, followed by an MS in biochemistry at Beijing University. He served as a research associate at USC in the Department of Orthopedic Surgery and subsequently joined the Dumont-UCLA Transplant Center. Dr. Qiao then joined the laboratory of Tomas Ganz, PhD, MD, UCLA Center for Iron Disorders, where he developed an interest in liver disease. He is now joining the laboratories of Jihane N. Benhammou, MD, PhD, and Noam Jacob, MD, PhD, to continue his work on metabolism and the gut-liver axis.

Farzaneh Sedighian

Farzaneh Sedighian
Research Associate

Farzaneh will be working as a research associate with Dr. Jacob, investigating cellular and molecular pathways involved in the gut microbiome's impact on intestinal fibrosis in Crohn's disease. She will examine the effects of specific bacterial species and microbial metabolites on fibroblast function in models of IBD. She will also evaluate how pro-fibrotic/inflammatory cytokines and the gut microbiome may work in concert to promote intestinal fibrosis.

Farzaneh has a master’s degree in medical microbiology, and holds a U.S. Patent for a medical biosensor kit. Her bachelor's degree is in cellular- molecular biology and microbiology. Before joining the department, Farzaneh worked with UCLA MIMG (Microbiology, Immunology and Molecular Genetics) department labs.


Key publications

  1. Jacob N, Kumagai K, Abraham JP, Shimodaira Y, Ye Y, Targan SR, Michelsen KS, Shih DQ. Direct Signaling of TL1A-DR3 on Fibroblasts Induces Intestinal Fibrosis In Vivo. Manuscript in preparation
  2. Jacob N, Jacobs J, Kumagai K, Ha CWY, Kanazawa Y, Lagishetty V, Altmayer K, Hamill AM, Von Arx A, Balfour S, Devkota S, Braun J, Michelsen KS, Targan SR, Shih DQ. Differing Microbial Populations Induce Tl1a-mediated Intestinal Fibrosis. In Press, Mucosal Immunology, 2018
  3. Jacob N, Targan SR, Shih DQ. “Cytokine and Anti-Cytokine Agents as Future Therapeutics for Fibrostenosing IBD.” Fibrostenotic Inflammatory Bowel Disease, Ed. Florian Rieder, Springer International Publishing, 2018
  4. Jacob N, Targan SR, Shih DQ. Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD. United European Gastroenterol J. 2016; 4:531-40
  5. Jacob N, Guo S, Mathian A, Koss MN, Gindea S, Putterman C, Jacob CO, Stohl W. B Cell and BAFF dependence of IFNa-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. The Journal of Immunology. 2011; 186: 4984-93
  6. Jacob N, Stohl W. Cytokine disturbances in systemic lupus erythematosus. Arthritis Research & Therapy. 2011; 13: 228
  7. Jacob N, Stohl W. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity. 2010; 43: 84-97
  8. Stohl W, Jacob N, Guo S, Morel L. Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity. Arthritis and Rheumatism. 2010; 62: 2432-42
  9. Jacob N, Yang H, Pricop L, Liu Y, Gao X, Zheng SG, Wang J, Gao HX, Putterman C, Koss MN,Stohl W, Jacob CO. Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway. The Journal of Immunology. 2009; 182: 2532-41
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth